| Overall N = 44 (%) | Masquelet N = 17 (%) | Vascularized bone N = 27 (%) | p-value |
---|---|---|---|---|
Age (mean ± SD) | 37.41 ± 15.43 | 43.71 ± 16.37 | 33.44 ± 13.65 | 0.03 |
Sex | Â | Â | Â | 0.473 |
Female | 10 (22.7%) | 5 (29.4%) | 5 (18.5%) | Â |
Male | 34 (77.3%) | 12 (70.6%) | 22 (81.5%) | Â |
BMI (mean ± SD) | 25.32 ± 4.40 | 25.88 ± 3.86 | 24.94 ± 4.77 | 0.487 |
Fracture type | Â | Â | Â | 0.521 |
IIIA | 4 (9.1%) | 2 (11.8%) | 2 (7.4%) | Â |
IIIB | 23 (52.3%) | 7 (41.2%) | 16 (59.3%) | Â |
IIIC | 17 (38.6%) | 8 (47.1%) | 9 (33.3%) | Â |
Fracture site | Â | Â | Â | 0.577 |
Proximal metaphysis | 10 (22.7%) | 3 (17.6%) | 7 (25.9%) | Â |
Diaphysis | 20 (45.5%) | 7 (41.2%) | 13 (48.1%) | Â |
Distal metaphysis | 14 (31.8%) | 7 (41.2%) | 7 (25.9%) | Â |
Bone gap (mean ± SD) | 74.83 ± 42.67 | 51.16 ± 16.23 | 94.94 ± 47.97 | 0.001 |
With Fibula | 42 (95.5%) | 17 (100.0%) | 25 (92.6%) | 0.515 |
Vascular or nerve injury | 18 (40.9%) | 9 (52.9%) | 9 (33.3%) | 0.255 |
MESS (mean ± SD) | 4.50 ± 1.41 | 4.94 ± 1.20 | 4.22 ± 1.48 | 0.099 |
AOIO* | Â | Â | Â | 0.102 |
3 | 17 (38.6%) | 4 (23.5%) | 13 (48.1%) | Â |
4 | 27 (61.4%) | 13 (76.5%) | 14 (51.9%) | Â |
AOMT* | Â | Â | Â | 0.431 |
3 | 15 (34.1%) | 7 (41.2%) | 8 (29.6%) | Â |
4 | 29 (65.9%) | 10 (58.8%) | 19 (70.4%) | Â |
AONV* | Â | Â | Â | 0.244 |
1 | 23 (52.3%) | 7 (41.2%) | 16 (59.3%) | Â |
2 | 2 (4.5%) | 0 (0.0%) | 2 (7.4%) | Â |
3 | 19 (43.2%) | 10 (58.8%) | 9 (33.3%) | Â |
ISS > 16 | 7 (15.9%) | 3 (17.6%) | 4 (14.8%) | 0.863 |
DM** | 2 (4.5%) | 1 (5.9%) | 1 (3.7%) | 0.736 |
HTN*** | 2 (4.5%) | 1 (5.9%) | 1 (3.7%) | 0.736 |
Smoking | 20 (45.5%) | 6 (35.3%) | 14 (51.9%) | 0.283 |
Infection before surgery | 26 (59.1%) | 11 (64.7%) | 15 (55.6%) | 0.548 |